Dimitrios Tzanis, MD, PhD

Institut Curie
Paris, Ile-de-France, France

Disclosure information not submitted.

Presentation(s):

• Paper 38 - DEFINING NOVEL BENCHMARK VALUES FOR OUTCOMES OF COMPREHENSIVE RESECTION OF PRIMARY RETROPERITONEAL LIPOSARCOMA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 39 - HISTOLOGIC ORGAN INFILTRATION AND RELATION WITH SURGEON PREOPERATIVE ASSESSMENT IN RETROPERITONEAL SARCOMA. A STUDY FROM TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 42 - HISTOLOGY AND MALIGNANCY GRADE ACCURACY OF PREOPERATIVE BIOPSY OF PRIMARY RETROPERITONEAL SARCOMA. A STUDY FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 47 - TARGETING DEDIFFERENTIATED LIPOSARCOMA CELL OF ORIGIN WITH TGF-BETA INHIBITION

  Friday, November 15, 2024
  9:00 AM – 10:00 AM PST